-22% Off

Sitalembic M-100/1000 SR Tablet 15’S

Original price was: ₹225.00.Current price is: ₹175.50.

  • Composition: Sitagliptin 100mg + Metformin Hydrochloride 1000mg
  • Manufacturer/Marketer – Alembic
  • To be sold on the prescription of registered medical practitioner only
Compare
Category:

Description

Sitalembic M-100/1000 SR Tablet 15’S

Sitalembic M SR 100/1000 Tablet 15’s is a combination drug of Sitagliptin (DPP4 inhibitors) and Metformin (Biguanides), belonging to the class of anti-diabetic. Type 2 diabetes is a condition in which either the body stops producing enough insulin (the hormone which helps to decrease sugar levels in the blood), or there is resistance to the action of insulin. As a result, insulin is produced in large amounts, but it cannot act on the body’s organs. Sitagliptin belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors that work by increasing the amounts of certain natural substances that lower blood sugar when it is high. Another medicine, Metformin, belongs to the class of biguanides that lower glucose production in the liver, delay glucose absorption from the intestines, and increase the body’s sensitivity to insulin. Thus Sitalembic M SR 100/1000 Tablet 15’s controls blood glucose levels from rising to very high after meals. Sitalembic M SR 100/1000 Tablet 15’s should be taken with food to avoid an upset stomach. Sitalembic M SR 100/1000 Tablet 15’s should be taken at the same time of the day each time for best results. For better advice, your doctor will decide what dose should be taken, and it can change in time depending on your condition. The most common side effect of Sitalembic M SR 100/1000 Tablet 15’s is hypoglycemia (low blood glucose levels) characterised by dizziness, sweating, palpitations, hunger pangs, dry mouth and skin etc. So, to avoid hypoglycemia, you should not miss meals and also should carry some form of sugar along with you. Other side effects include taste change, nausea, diarrhoea, stomach pain, headache, and upper respiratory symptoms.